Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • Nepal protests
  • Nepal Protests Live
  • Vice-presidential elections
  • iPhone 17
  • IND vs PAK cricket
  • Israel-Hamas war
fp-logo
Researchers claim they have developed a 99% accurate blood test to detect 12 different types of cancer
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
  • Home
  • Health
  • Researchers claim they have developed a 99% accurate blood test to detect 12 different types of cancer

Researchers claim they have developed a 99% accurate blood test to detect 12 different types of cancer

Myupchar • October 3, 2019, 16:50:11 IST
Whatsapp Facebook Twitter

Earlier this year GRAIL inc. announced that their researchers have developed a blood test to detect 12 different types of cancer in the early stages.

Advertisement
Subscribe Join Us
Add as a preferred source on Google
Prefer
Firstpost
On
Google
Researchers claim they have developed a 99% accurate blood test to detect 12 different types of cancer

Earlier this year GRAIL inc., a biotechnology company in California, US, announced that their researchers have developed a blood test to detect 12 different types of cancer in the early stages. The company also claimed that the test is 99% accurate — with just 1% chance of false-positive — and a 94% chance of finding out the tissue of origin of cancer. Now, the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School, has corroborated these findings, saying that the blood test devised by GRAIL may actually give a correct diagnosis for cancer in 99.4% cases. [caption id=“attachment_7335521” align=“alignleft” width=“380”] ![Representational image. Image by PDPics from Pixabay ](https://images.firstpost.com/wp-content/uploads/2019/09/cancer-389921_1280_1.jpg) Representational image.
Image by PDPics from Pixabay[/caption] Globally, one in six deaths occurs due to cancer. Scientists all over the world have been looking for easier and quick detection techniques that can help them stop disease progression at an early stage. The GRAIL research may a significant stepping stone on this path. The four-part research was published in the  Journal of Clinical Oncology, a peer-reviewed medical journal by the American Society of Clinical Oncology. The cancer types it looked for included anorectal, colorectal, oesophagal, gastric, head and neck, hormone receptor-negative breast, liver, lung, ovarian, and pancreatic cancers, and multiple myeloma and lymphoid neoplasms.

The research

Scientists at GRAIL inc. focused on something known as circulating tumour DNA (ctDNA) and methylation markers. ctDNA is a specific type of DNA that tumour cells release into the bloodstream after they die. Cancer cells function a lot like normal cells. Just like healthy cells, cancer cells die and new cells are constantly formed to replace the dead cells. Methylation is a process that attaches specific methyl groups on DNA. It determines which fragment of DNA is going to be active - the region which gets methylated is suppressed. Specific methylations in healthy cells make them grow uncontrollably or turn into cancer. ctDNA carries these methylations on their surface and is hence different from normal cell DNA. While the findings are new, the research goes back a few years. The method seems to be based on the liquid biopsy procedure, something that GRAIL inc focuses on. Liquid biopsy, which involves sampling body fluids, mainly blood, to look for disease conditions, is now being used in cancer research. Though it is not really a new concept - we already use amniotic fluid samples to check for developmental abnormalities in foetuses. Currently, liquid biopsies are being used for the early detection of cancer — months before — though they look for cancer-related changes in DNA or genetic mutations that can lead to cancer. This is a tedious task since cancer DNA is present in small quantities in the blood and sequencing the DNA samples takes time. Also, the existing methods could only detect one cancer at a time. On the other hand, focusing on methylation pattern has helped the scientists look for more than one type of cancer with a single test. The dual benefit of this test comes in the form of tissue detection - detecting the tissue where cancer started. Specific methylated regions are present in different body tissues. In a press release, GRAIL’s Chief Executive Officer Jeniffer Cook said: “Our improved methylation-based technology has the potential to address gaps that exist with today’s screening options, which are limited to a few cancer types and only screen for one cancer type at a time. Based on these positive data, we plan to advance the development of our test toward commercialization.” Oncologist Geoffrey Oxnard from Dana-Farber said, “Such assays are a feasible way of screening people for cancer. If the test were in wide use, it could help patients receive more effective treatments.” Health articles in Firstpost are written by myUpchar.com, India’s first and biggest resource for verified medical information. At myUpchar, researchers and journalists work with doctors to bring you information on all things health. For more information, please read our in-depth article on   Cancer: Causes, Types, Diagnosis and Treatment_._

Tags
NewsTracker Cancer Ovarian cancer Lung cancer cancer research liquid biopsy test cancer detection Methylation
End of Article
Latest News
Find us on YouTube
Subscribe
End of Article

Impact Shorts

Doctor Explains | Why Pap smears can’t detect ovarian cancer and which tests women should rely on instead

Doctor Explains | Why Pap smears can’t detect ovarian cancer and which tests women should rely on instead

Ovarian cancer, often called a "silent killer," is usually detected late due to vague symptoms like bloating, pelvic pain, and frequent urination. Risk factors include family history and BRCA mutations. Treatment includes surgery, chemotherapy, and PARP inhibitors. Awareness and genetic testing are

More Impact Shorts

Top Stories

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV